Title:
THERAPY DEVICE KIT
Document Type and Number:
WIPO Patent Application WO/2023/048230
Kind Code:
A1
Abstract:
The purpose of the present invention is to provide a method having a superior anti-tumor effect. [Solution] A therapy device kit having an anti-cancer drug for inducing immunogenic cell death and an administration device capable of administering the anti-cancer drug to tumor tissue, the anti-cancer drug inducing activation of anti-tumor immunity due to being administered using the administration device.
More Like This:
| WO/2001/021793 | p21?Cip1¿ REMEDIES FOR RHEUMATISM |
| JP2023518396 | Cancer therapy by inhibiting CARM1 |
| WO/2002/078716 | METHYLATED PROMOTERS FOR INTRADUCTAL TREATMENT OF BREAST CANCER |
Inventors:
ARIMA HIROKI (JP)
NOZAWA SHIGENORI (JP)
HIRAMITSU MASAKI (JP)
OTSU KEIKO (JP)
KOMEDA YOSHIKI (JP)
NOZAWA SHIGENORI (JP)
HIRAMITSU MASAKI (JP)
OTSU KEIKO (JP)
KOMEDA YOSHIKI (JP)
Application Number:
PCT/JP2022/035371
Publication Date:
March 30, 2023
Filing Date:
September 22, 2022
Export Citation:
Assignee:
TERUMO CORP (JP)
International Classes:
A61K45/00; A61K31/282; A61K31/337; A61K31/704; A61K39/395; A61M5/158; A61M5/168; A61P35/00; A61P43/00; A61M5/178
Domestic Patent References:
| WO2012128129A1 | 2012-09-27 | |||
| WO2022168862A1 | 2022-08-11 | |||
| WO2022138740A1 | 2022-06-30 |
Foreign References:
| US9399101B1 | 2016-07-26 |
Other References:
SHI YINGGE, LI DONG, HE CHAOLIANG, CHEN XUESI: "Design of an Injectable Polypeptide Hydrogel Depot Containing the Immune Checkpoint Blocker Anti‐PD‐L1 and Doxorubicin to Enhance Antitumor Combination Therapy", MACROMOLECULAR BIOSCIENCE, WILEY-VCH VERLAG GMBH, DE, vol. 21, no. 6, 1 June 2021 (2021-06-01), DE , pages 2100049, XP093051273, ISSN: 1616-5187, DOI: 10.1002/mabi.202100049
Attorney, Agent or Firm:
HATTA & ASSOCIATES (JP)
Download PDF: